Metformin (Longevity Use)
Affiliate link: we may earn a commission at no extra cost to you. Disclosures
Metformin (Longevity Use). Biguanide diabetes drug studied for healthspan.
How it works. Inhibits mitochondrial complex I; activates AMPK.
What the research supports. 1 graded claims. Strongest: May reduce age-related diseases (moderate).
How much to take. Typical dose: 500–1500 mg (Rx only).
Side effects and interactions. 1 medication interaction listed. No serious side effects listed at normal doses.
Stacking. Pairs well with NAD+ precursor (NMN or NR), Omega-3.
Common forms. Available as Capsule or softgel, Powder, Sublingual or buccal, Liposomal liquid.
Key studies. 8 studies cited. The strongest are listed with links to PubMed.
Community. Experiences from people who have tried Metformin (Longevity Use). Anecdotes are not medical advice.
Metformin (Longevity Use). Biguanide diabetes drug studied for healthspan.
What it is
Biguanide diabetes drug studied for healthspan.
Food sources
Goals
How it works
Inhibits mitochondrial complex I; activates AMPK.
Pathways
- Inhibits mitochondrial complex I
- activates AMPK
Effects
- +May reduce age-related diseases supports
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
As an Amazon Associate I earn from qualifying purchases. Look for USP, NSF or Informed Sport seals before you buy.
Side effects & interactions
Common side effects
- GI upset
- B12 deficiency
- Lactic acidosis (rare)
Medication interactions
Always disclose Metformin (Longevity Use) use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.
Check any supplement–medication combination with your pharmacist before starting.
Combines with
Pairs well
- NAD+ precursor (NMN or NR)Complementary mitochondrial and sirtuin support.
- Omega-3Lowers inflammation and supports membrane integrity.
Common forms
- Capsule or softgel
- Powder
- Sublingual or buccal
- Liposomal liquid
Key studies
8 studies cited in total.
Opens current human and preclinical literature matching Metformin (Longevity Use) and "May reduce age-related diseases". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching Metformin (Longevity Use) and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching Metformin (Longevity Use) and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.
Discussion
Loading discussion…